Copyrights
Causality is committed to the open access model as the backbone of its editorial policy, in line with the principles of global dissemination of scientific knowledge. Within this framework, authorship policies are designed to maximize the visibility, reach, and impact of published research, establishing a transfer of exploitation rights to the publisher that guarantees the preservation of and perpetual access to content.
Attribution 4.0 International - The Author is free to:
Share — copy and redistribute the material in any medium or format for any purpose, including commercial purposes.
Adapt — remix, transform, and build upon the material for any purpose, including commercial purposes.
The licensor cannot revoke these freedoms as long as the terms of the license are respected.
Under the following terms:
Attribution — You must give appropriate attribution, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Avisos
You do not have to comply with the license for elements of the material in the public domain or when its use is permitted by an applicable exception or limitation.
No warranty is offered. The license may not grant you all the permissions you need for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit your use of the material.
The author policies at Causality Open Access are designed to empower researchers. By shifting the focus from restriction to permissiveness through Creative Commons licenses, scientific knowledge is guaranteed to be disseminated as widely and efficiently as possible, thus accelerating innovation and progress in the field of engineering. Authors gain visibility, control over their work, and comply with funder mandates, while society benefits from barrier-free access to the latest scientific advances.







